Kwon, M., Iacoboni, G., Reguera, J. L., López Corral, L., Hernani Morales, R., Ortiz-Maldonado Gibson, V., . . . Barba, P. (2022). Axicabtagene ciloleucel compared to tisagenlecleucel for the treatment of aggressive B-cell lymphoma.
Citación estilo ChicagoKwon, Mi, et al. Axicabtagene Ciloleucel Compared to Tisagenlecleucel for the Treatment of Aggressive B-cell Lymphoma. 2022.
Cita MLAKwon, Mi, et al. Axicabtagene Ciloleucel Compared to Tisagenlecleucel for the Treatment of Aggressive B-cell Lymphoma. 2022.
Precaución: Estas citas no son 100% exactas.